ATLANTA KETAMINE CENTER

Serial Number 98156750
Registration 7476835
700

Registration Progress

Application Filed
Aug 29, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered
Aug 13, 2024

Trademark Image

ATLANTA KETAMINE CENTER

Basic Information

Serial Number
98156750
Registration Number
7476835
Filing Date
August 29, 2023
Registration Date
August 13, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 13, 2024
Registration
Registered
Classes
044

Rights Holder

Northland Medical, LLC

16
Address
270 Carpenter Drive
Suite 515
Atlanta, GA 30328

Ownership History

Northland Medical, LLC

Original Applicant
16
Atlanta, GA

Northland Medical, LLC

Original Registrant
16
Atlanta, GA

Legal Representation

Attorney
Wayne Lazarus

USPTO Deadlines

Next Deadline
1833 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-13)
Due Date
August 13, 2030
Grace Period Ends
February 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

10 events
Date Code Type Description Documents
Aug 13, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 13, 2024 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Jul 10, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 10, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 10, 2024 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Jul 10, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 10, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 8, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical treatment of depression, anxiety, obsessive-compulsive disorder, post-traumatic stress disorder, and pain; Medical services, namely, ketamine infusions for the treatment of depression, anxiety, obsessive-compulsive disorder, pain, and post-traumatic stress disorder
First Use Anywhere: Jan 1, 2023
First Use in Commerce: Jan 1, 2023

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"KETAMINE CENTER"